BACKGROUND: Neurocognitive deficits from brain tumours may impair the ability to safely operate a motor vehicle. Although certain jurisdictions in Canada legally require that physicians report patients who are unfit to drive, criteria for determining fitness are not clearly defined for brain tumours. METHODS: Patients receiving brain radiotherapy at our institution from January to June 2009 were identified using the Oncology Patient Information System. In addition to descriptive statistics, details of driving assessment were reviewed retrospectively. The Fisher exact test was used to determine factors predictive of reporting a patient to the Ontario Ministry of Transportation (mto) as unfit to drive. A logistic regression model was constructed to further determine factors predictive of reporting. RESULTS: Of the 158 patients available for analysis, 48 (30%) were reported to the mto, and 64 (41%) were advised to stop driving. With respect to the 53 patients with seizures, a report was submitted to the mto for 30 (57%), and a documented discussion about the implications of driving was held with 35 (66%). On univariate analysis, younger age, a central nervous system primary, higher brain radiotherapy dose, unifocal disease, and the presence of seizures were predictive of physician reporting (p < 0.05). On logistic regression modelling, the presence of seizures (odds ratio: 3.9) and a higher radiotherapy dose (odds ratio: 1.3) remained predictive of reporting. INTERPRETATION: Physicians frequently do not discuss the implications of driving with brain tumour patients or are not properly documenting such advice (or both). Clear and concise reporting guidelines need to be drafted given the legal, medical, and ethical concerns surrounding this public health issue.
BACKGROUND:Neurocognitive deficits from brain tumours may impair the ability to safely operate a motor vehicle. Although certain jurisdictions in Canada legally require that physicians report patients who are unfit to drive, criteria for determining fitness are not clearly defined for brain tumours. METHODS:Patients receiving brain radiotherapy at our institution from January to June 2009 were identified using the Oncology Patient Information System. In addition to descriptive statistics, details of driving assessment were reviewed retrospectively. The Fisher exact test was used to determine factors predictive of reporting a patient to the Ontario Ministry of Transportation (mto) as unfit to drive. A logistic regression model was constructed to further determine factors predictive of reporting. RESULTS: Of the 158 patients available for analysis, 48 (30%) were reported to the mto, and 64 (41%) were advised to stop driving. With respect to the 53 patients with seizures, a report was submitted to the mto for 30 (57%), and a documented discussion about the implications of driving was held with 35 (66%). On univariate analysis, younger age, a central nervous system primary, higher brain radiotherapy dose, unifocal disease, and the presence of seizures were predictive of physician reporting (p < 0.05). On logistic regression modelling, the presence of seizures (odds ratio: 3.9) and a higher radiotherapy dose (odds ratio: 1.3) remained predictive of reporting. INTERPRETATION: Physicians frequently do not discuss the implications of driving with brain tumourpatients or are not properly documenting such advice (or both). Clear and concise reporting guidelines need to be drafted given the legal, medical, and ethical concerns surrounding this public health issue.
Entities:
Keywords:
Canadian heath care system; Driving; brain tumours; guidelines; radiation therapy
Authors: Chris Simpson; Paul Dorian; Anil Gupta; Robert Hamilton; Stephen Hart; Barry Hoffmaster; George Klein; Andrew Krahn; Peter Kryworuk; L Brent Mitchell; Paul Poirier; Heather Ross; Magdi Sami; Robert Sheldon; Jim Stone; Jan Surkes; F James Brennan Journal: Can J Cardiol Date: 2004-11 Impact factor: 5.223
Authors: Mark J Rapoport; Nathan Herrmann; Frank J Molnar; Malcolm Man-Son-Hing; Shawn C Marshall; Ken Shulman; Gary Naglie Journal: CMAJ Date: 2007-09-11 Impact factor: 8.262
Authors: Roger Baskett; Richard Crowell; Darren Freed; Nadia Giannetti; Christopher S Simpson Journal: Can J Cardiol Date: 2012-02-17 Impact factor: 5.223
Authors: A V Louie; D P D'Souza; D A Palma; G S Bauman; M Lock; B Fisher; N Patil; G B Rodrigues Journal: Curr Oncol Date: 2012-06 Impact factor: 3.677
Authors: Raymond W Jang; Malcolm Man-Son-Hing; Frank J Molnar; David B Hogan; Shawn C Marshall; Julie Auger; Ian D Graham; Nicol Korner-Bitensky; George Tomlinson; Matthew E Kowgier; Gary Naglie Journal: J Gen Intern Med Date: 2007-04 Impact factor: 5.128
Authors: Ayal A Aizer; Nayan Lamba; Manmeet S Ahluwalia; Kenneth Aldape; Adrienne Boire; Priscilla K Brastianos; Paul D Brown; D Ross Camidge; Veronica L Chiang; Michael A Davies; Leland S Hu; Raymond Y Huang; Timothy Kaufmann; Priya Kumthekar; Keng Lam; Eudocia Q Lee; Nancy U Lin; Minesh Mehta; Michael Parsons; David A Reardon; Jason Sheehan; Riccardo Soffietti; Hussein Tawbi; Michael Weller; Patrick Y Wen Journal: Neuro Oncol Date: 2022-10-03 Impact factor: 13.029